< Back to all clusters
[HEALTH] · United States · 6 sources

started · updated

Mayo Clinic study identifies gut microbiome signatures as potential cancer biomarkers

A Mayo Clinic study published in Cell has identified specific gut microbiome signatures that may serve as biomarkers for various cancers. By analyzing stool samples from 1,364 patients, researchers discovered distinct microbial patterns associated with five major cancer groups. Notably, the study found significant differences in patients diagnosed at younger ages, particularly regarding early-onset colorectal and breast cancers.

In patients aged 50 and younger with colorectal cancer, researchers observed higher lactate levels and an increase in the bacterium Veillonella parvula. Younger breast cancer patients showed changes across 64 bacterial species and lower levels of primary bile acids. These findings offer potential for predicting cancer progression and chemotherapy side effects.

Separately, research published in The Lancet Oncology by the International Agency for Research on Cancer (IARC) indicates that infectious agents play a major role in global cancer statistics. In 2024, an estimated 2.3 million cancer cases—approximately one in eight new diagnoses—were attributed to viruses, bacteria, or parasites.

Entities

Cell · International Agency for Research on Cancer · Mayo Clinic · Purna C. Kashyap · The Lancet Oncology

Claims

What the coverage asserts, and how many sources carry each claim.